The Vita Coco Company Inc vs Hims and Hers Health Inc — how do they compare? The Vita Coco Company Inc trades at $74.45 (market cap $4.23B), while Hims and Hers Health Inc trades at $35.54 (market cap $8.14B). The key difference: Hims and Hers Health Inc is the larger of the two by market cap, and The Vita Coco Company Inc is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals.
| COCO | HIMS | |
|---|---|---|
Market Cap | $4.23B | $8.14B |
Sector | Technology | Health |
52-Week High | $84.02 | $66.18 |
52-Week Low | $32.30 | $14.52 |
Enterprise Value | $4.04B | $8.52B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Hims & Hers Health trades at $34.38, showing no change in the last session. The stock exhibits a bullish technical setup with moving averages supporting upward momentum, while oscillators remain neutral. Recent earnings have been mixed, with Q1 2026 missing expectations, but revenue growth remains positive. Analyst sentiment is divided with a 35% buy rating, and the consensus price target is $33.57. News highlights include expansion in weight-loss treatments and a new JPMorgan receivables facility.
The outlook for HIMS is cautiously optimistic, driven by growth in telehealth and weight-loss segments, but high valuation multiples and recent net income declines pose risks. Investment opportunity lies in market expansion and subscriber growth, while execution risks and competitive pressures require monitoring.
Trailing returns across standard periods
Latest headlines on both assets
The Vita Coco Company is a leading functional beverage brand specializing in coconut water. Its portfolio includes its flagship Vita Coco brand, clean energy drinks, and sustainable enhanced water products.
Read more on COCO →Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →